Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.7950
-0.0450 (-5.36%)
May 12, 2026, 3:59 PM AEST
Cyclopharm Revenue
In the year 2025, Cyclopharm had annual revenue of 32.33M AUD with 17.24% growth. Cyclopharm had revenue of 16.90M in the half year ending December 31, 2025, with 68.21% growth.
Revenue
32.33M
Revenue Growth
+17.24%
P/S Ratio
3.10
Revenue / Employee
296.56K
Employees
97
Market Cap
100.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.33M | 4.75M | 17.24% |
| Dec 31, 2024 | 27.57M | 1.23M | 4.68% |
| Dec 31, 2023 | 26.34M | 1.48M | 5.97% |
| Dec 31, 2022 | 24.85M | 4.86M | 24.30% |
| Dec 31, 2021 | 20.00M | 2.31M | 13.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.10B |
| Sonic Healthcare | 10.42B |
| Sigma Healthcare | 9.55B |
| Pro Medicus | 240.57M |
| Austco Healthcare | 92.73M |
| Alterity Therapeutics | 6.64M |
| Arovella Therapeutics | 3.21M |
| Epiminder | 648.18K |
Cyclopharm News
- 9 months ago - Cyclopharm Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Cyclopharm Transcript: Investor Update - Transcripts